» Journals » J Cosmet Dermatol

Journal of Cosmetic Dermatology

The Journal of Cosmetic Dermatology is a peer-reviewed publication dedicated to advancing the understanding and practice of cosmetic dermatology. It provides a platform for researchers, clinicians, and industry professionals to share their latest findings, techniques, and innovations in the field. The journal covers a wide range of topics including skincare, aesthetic procedures, laser treatments, injectables, and cosmetic surgery, aiming to enhance the knowledge and expertise of dermatologists and other healthcare professionals involved in cosmetic dermatology.

Details
Abbr. J Cosmet Dermatol
Start 2002
End Continuing
Frequency Quarterly
p-ISSN 1473-2130
e-ISSN 1473-2165
Country United Kingdom
Language English
Specialty Dermatology
Metrics
h-index / Ranks: 6023 61
SJR / Ranks: 6232 707
CiteScore / Ranks: 7822 3.40
JIF / Ranks: 4670 2.3
Recent Articles
1.
2.
Haykal D
J Cosmet Dermatol . 2025 Mar; 24(3):e70125. PMID: 40087997
No abstract available.
3.
Takaya K, Kishi K
J Cosmet Dermatol . 2025 Mar; 24(3):e70123. PMID: 40087990
Background: Acquired dermal melanocytosis (ADM) is a pigmentary lesion caused by melanocytes in the dermis. These conditions are refractory, and a consensus on treatment remains elusive. Aims: To compare the...
4.
Gold M, Goldust M
J Cosmet Dermatol . 2025 Mar; 24(3):e16799. PMID: 40087989
No abstract available.
5.
Zhao X, Li P, Yang J
J Cosmet Dermatol . 2025 Mar; 24(3):e70059. PMID: 40084684
Objective: Sporotrichosis is the most prevalent deep mycosis worldwide. The differential diagnosis of its clinical symptoms and histopathological features presents considerable complexity. A thorough understanding of the clinical manifestations and...
6.
Ge S, Weiss R, Schilling L, Noell C
J Cosmet Dermatol . 2025 Mar; 24(3):e70072. PMID: 40084635
Introduction: The study investigates the efficacy of combining low-dose triamcinolone acetonide (TAC) and lidocaine with deoxycholic acid (DCA) injections to reduce adverse effects (AEs) without compromising long-term results. Methods: A...
7.
Gupta A, Bamimore M, Williams G, Talukder M
J Cosmet Dermatol . 2025 Mar; 24(3):e70102. PMID: 40082195
Background: Oral finasteride 1 mg/day is indicated for androgenetic alopecia (AGA), while 5 mg/day is for benign prostatic hyperplasia (BPH). Oral finasteride has been linked with depression and suicide; however,...
8.
Burko P, Sulamanidze G, Nikishin D
J Cosmet Dermatol . 2025 Mar; 24(3):e70077. PMID: 40071656
Background: Facial thread lifting, which is popular in aesthetic medicine because of its minimal invasiveness, has led to advancements in the use of biodegradable polymers such as poly(L-lactide-co-ε-caprolactone) (P(LA/CL)) and...
9.
Stolarski M, Sanabria B, Kwarteng L, Rao B
J Cosmet Dermatol . 2025 Mar; 24(3):e70091. PMID: 40071624
No abstract available.
10.
Shirasugi Y, Shibata T, Koike S, Hara M, Hasegawa K, Iino M, et al.
J Cosmet Dermatol . 2025 Mar; 24(3):e70112. PMID: 40071590
Background: Hyperpigmentation is a common acquired disorder that can be a cosmetic concern for many individuals. To reduce and prevent hyperpigmentation, numerous skin lightening agents have been developed. Potassium 4-methoxysalicylate...